2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Rare Cancers
While rare cancers individually affect fewer people, collectively they pose a significant health challenge. Due to their infrequency, research and resources are often limited compared to more common cancers. However, understanding and treating rare cancers are crucial for advancing oncology as a whole. Innovative approaches such as precision medicine, which tailors treatments to individuals based on genetic makeup, are showing promise in addressing rare cancers. Collaboration among researchers, clinicians, and patients is key to driving progress in this field. Moreover, initiatives to increase awareness, funding, and clinical trials specific to rare cancers are essential for improving diagnosis and treatment outcomes. By focusing efforts on these less common but equally critical cancers, we can broaden our understanding of cancer biology and ultimately improve patient care and survival rates.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China